\-\ Texto\\:\\ \ \(0\)\
\-\ assymetry\\ of\\ parotid\\ region\ \(0\)\
\-\ large\\,\\ well\\-defined\\ heterogeneous\\ soft\\ tissue\\ mass\\ within\\ the\\ left\\ parotid\\ gland\\,\\ inferior\\ to\\ the\\ mastoid\\ process\\ with\\ apparent\\ extension\\ into\\ the\\ mastoid\\ segment\\ of\\ the\\ facial\\ nerve\\ canal\\.\\ \\ \ \(0\)\
\-\ there\\ is\\ partial\\ cystic\\ degeneration\\ within\\ the\\ lesion\\.\\ \\ \\ \\ there\\ was\\ normal\\ signal\\ in\\ the\\ labyrinthine\\,\\ tympanic\\ and\\ intracanalicular\\ segments\\ of\\ the\\ facial\\ nerve\\.\ \(0\)\
\-\ facial\\ nerve\\ schwannoma\ \(0\)\
\-\ \\â\\€\\¢\\ facial\\ nerve\\ schwannoma\ \(0\)\
\-\ \\â\\€\\¢\\ perineural\\ spread\\:\\ lymphoma\\,\\ adenoid\\ cystic\\ carcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ pleomorphic\\ adenoma\\ \\(high\\ t2\\ signal\\)\ \(0\)\
\-\ \\â\\€\\¢\\ benign\\ lymphoepithelial\\ cysts\\:\\ mixed\\ solid\\ and\\ cystic\\ intraparotid\\ lesions\\ \\(high\\ t2\\ signal\\,\\ hiv\\ patients\\)\ \(0\)\
\-\ \\â\\€\\¢\\ other\\ parotid\\ masses\\:\\ benign\\ mixed\\ tumor\\,\\ warthin\\ tumor\\,\\ non\\ hodgkin\\ lymphona\\,\\ parotid\\ metastasis\\,\\ mucoepidermoid\\ carcinoma\ \(0\)\
\-\ 23\\ y\\.o\\.\\ woman\\ with\\ gradually\\ enlarging\\ left\\ parotid\\ mass\\.\\ \\ the\\ patient\\ complained\\ of\\ sharp\\ pain\\ in\\ her\\ left\\ face\\ along\\ with\\ twitching\\ of\\ her\\ left\\ eye\\,\\ and\\ difficulty\\ hearing\\ out\\ of\\ left\\ ear\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parotid\\:\\ 0\\.17962302933371935\ \(0\)\
\-\ facial\\:\\ 0\\.09174449373190863\ \(0\)\
\-\ nerve\\:\\ 0\\.07602336114783471\ \(0\)\
\-\ mastoid\\:\\ 0\\.060786396615504584\ \(0\)\
\-\ intraparotid\\:\\ 0\\.054416780394854924\ \(0\)\
\-\ labyrinthine\\:\\ 0\\.05013809409510218\ \(0\)\
\-\ lymphoepithelial\\:\\ 0\\.05013809409510218\ \(0\)\
\-\ lymphona\\:\\ 0\\.05013809409510218\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.04836464048135456\ \(0\)\
\-\ schwannoma\\:\\ 0\\.04818350047198082\ \(0\)\
\-\ mixed\\:\\ 0\\.04633238754246335\ \(0\)\
\-\ cystic\\:\\ 0\\.04564134643058811\ \(0\)\
\-\ assymetry\\:\\ 0\\.044481978466249364\ \(0\)\
\-\ warthin\\:\\ 0\\.043356536757644705\ \(0\)\
\-\ mucoepidermoid\\:\\ 0\\.043356536757644705\ \(0\)\
\-\ twitching\\:\\ 0\\.04240498935130361\ \(0\)\
\-\ signal\\:\\ 0\\.04172359870875516\ \(0\)\
\-\ perineural\\:\\ 0\\.041580721495596676\ \(0\)\
\-\ intracanalicular\\:\\ 0\\.04085366571993999\ \(0\)\
\-\ adenoid\\:\\ 0\\.03730203519584393\ \(0\)\
\-\ benign\\:\\ 0\\.036408029222632116\ \(0\)\
\-\ tympanic\\:\\ 0\\.03407210838248252\ \(0\)\
\-\ hodgkin\\:\\ 0\\.032833400385802576\ \(0\)\
\-\ her\\:\\ 0\\.03172113158623377\ \(0\)\
\-\ gradually\\:\\ 0\\.030650437174422465\ \(0\)\
\-\ carcinoma\\:\\ 0\\.02990034160513415\ \(0\)\
\-\ t2\\:\\ 0\\.029859120601856196\ \(0\)\
\-\ segments\\:\\ 0\\.029680155794654488\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.029680155794654488\ \(0\)\
\-\ left\\:\\ 0\\.02950942189113934\ \(0\)\
\-\ hiv\\:\\ 0\\.02924679617321468\ \(0\)\
\-\ high\\:\\ 0\\.028870939025639697\ \(0\)\
\-\ sharp\\:\\ 0\\.028554714086049825\ \(0\)\
\-\ complained\\:\\ 0\\.02784847735038474\ \(0\)\
\-\ well\\-defined\\:\\ 0\\.027139986519567283\ \(0\)\
\-\ enlarging\\:\\ 0\\.02684944632908589\ \(0\)\
\-\ degeneration\\:\\ 0\\.026778898824001796\ \(0\)\
\-\ hearing\\:\\ 0\\.02598980393813831\ \(0\)\
\-\ ear\\:\\ 0\\.02598980393813831\ \(0\)\
\-\ face\\:\\ 0\\.025867565498038435\ \(0\)\
\-\ spread\\:\\ 0\\.025514735782977027\ \(0\)\
\-\ 23\\:\\ 0\\.02507363106703786\ \(0\)\
\-\ tumor\\:\\ 0\\.024595460513713717\ \(0\)\
\-\ difficulty\\:\\ 0\\.023486932900433594\ \(0\)\
\-\ apparent\\:\\ 0\\.02332448037995598\ \(0\)\
\-\ segment\\:\\ 0\\.02301186474527231\ \(0\)\
\-\ gland\\:\\ 0\\.022465238835757215\ \(0\)\
\-\ eye\\:\\ 0\\.022125986463653772\ \(0\)\
\-\ adenoma\\:\\ 0\\.02202774291238279\ \(0\)\
\-\ non\\:\\ 0\\.021804411698941418\ \(0\)\
\-\ partial\\:\\ 0\\.02109478841017744\ \(0\)\
\-\ solid\\:\\ 0\\.021039176867323327\ \(0\)\
\-\ canal\\:\\ 0\\.020956687806754394\ \(0\)\
\-\ \\:\\:\\ 0\\.020931015110938242\ \(0\)\
\-\ cysts\\:\\ 0\\.020663322733526956\ \(0\)\
\-\ process\\:\\ 0\\.02030904620268342\ \(0\)\
\-\ within\\:\\ 0\\.02012507911587755\ \(0\)\
\-\ metastasis\\:\\ 0\\.019745353866048927\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.019396266399969168\ \(0\)\
\-\ extension\\:\\ 0\\.01882918099494848\ \(0\)\
\-\ inferior\\:\\ 0\\.01789701457629051\ \(0\)\
\-\ masses\\:\\ 0\\.017830817271580784\ \(0\)\
\-\ along\\:\\ 0\\.017432431338632814\ \(0\)\
\-\ out\\:\\ 0\\.017432431338632814\ \(0\)\
\-\ \\,\\:\\ 0\\.016710497871437493\ \(0\)\
\-\ there\\:\\ 0\\.015700192055123317\ \(0\)\
\-\ y\\.o\\:\\ 0\\.015224564398683334\ \(0\)\
\-\ lymphoma\\:\\ 0\\.015075300212280774\ \(0\)\
\-\ region\\:\\ 0\\.014898773007650077\ \(0\)\
\-\ mass\\:\\ 0\\.014672358110463758\ \(0\)\
\-\ lesions\\:\\ 0\\.014120743866320664\ \(0\)\
\-\ patients\\:\\ 0\\.013651695057814973\ \(0\)\
\-\ soft\\:\\ 0\\.01284522693823179\ \(0\)\
\-\ into\\:\\ 0\\.012551397333084609\ \(0\)\
\-\ tissue\\:\\ 0\\.012502599928719714\ \(0\)\
\-\ woman\\:\\ 0\\.012184586095610532\ \(0\)\
\-\ other\\:\\ 0\\.01215826264631141\ \(0\)\
\-\ large\\:\\ 0\\.011534212542167159\ \(0\)\
\-\ lesion\\:\\ 0\\.0107441680617312\ \(0\)\
\-\ \\(\\:\\ 0\\.008918046003010624\ \(0\)\
\-\ \\)\\:\\ 0\\.008809107310040804\ \(0\)\
\-\ normal\\:\\ 0\\.0082692126827105\ \(0\)\
\-\ the\\:\\ 0\\.006827125170549422\ \(0\)\
\-\ pain\\:\\ 0\\.0064420257254983624\ \(0\)\
\-\ was\\:\\ 0\\.006100478532183252\ \(0\)\
\-\ patient\\:\\ 0\\.005287604511829555\ \(0\)\
\-\ in\\:\\ 0\\.005202434940003147\ \(0\)\
\-\ of\\:\\ 0\\.004314955585110683\ \(0\)\
\-\ is\\:\\ 0\\.0034709307307699113\ \(0\)\
\-\ and\\:\\ 0\\.0033335001061521935\ \(0\)\
\-\ to\\:\\ 0\\.0026362228916233716\ \(0\)\
\-\ with\\:\\ 0\\.0021667440016646246\ \(0\)\
\-\ \\.\\:\\ 0\\.0013147976332350472\ \(0\)\
